Clinical Trial Update: Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluated microsphere-delivered cytokines to boost tumor lymphocyte response in patients with head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Microsphere-delivered cytokines

Snippet

Sponsor: NYU Langone Health | Conditions: Head and Neck Cancer | NA | Status: COMPLETED